Post

RNA from a patient’s excised tumor was isolated and used to create a personalized vaccine. Amplifying the tumor’s messenger RNA (mRNA) presented the tumor cells to the immune system as a virus eliciting a targeted immune response upon reentry into the bloodstream! medicalxpress.com/news/2024-05...

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumormedicalxpress.com In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggre...

That's impressive. Many years ago I worked for a tumor virologist at Harvard Medical School so these advances are always wonderful to read about.